Abstract
Reported mediastinal recurrence rates in SBRT for stage I NSCLC are low relative to patients who undergo surgical resection (7%-21%). We hypothesized whether incidental dose to the mediastinum could account for the low rates of recurrence in these patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
